Medical emergency? Call 112 or your local emergency number immediately.
Updated 2 Oct 2026 · data to week 39 (21–27 Sep 2026)

RSV in Europe right now

The RSV season has not started yet: 0.1% of 1,175 GP sentinel swabs across the EU/EEA were positive for RSV in week 39 (21–27 Sep 2026).The 2026/27 season starts in week 40 (28 Sep – 4 Oct 2026); its first figures arrive about a week later.

ECDC/WHO sentinel data, recalculated every week · Medical review pending

On this pageThis week at a glanceTrendBy countryAbout RSV seasonIf you are illHow to read the numbersQuestions people askSources

This week at a glance

  • RSV: 0.1% positive across the EU/EEA in week 39 (1 of 1,175 swabs), baseline, stable.
  • Same week last year across the EU/EEA: 0.2%.
  • Highest this week (solid samples only): Spain, 0.2%.
  • Last season (2025/26) RSV peaked across the EU/EEA at 14.5% in week 8.

RSV across the EU/EEA: this season and the last three

2025/262024/252023/243%: end of baseline
0%5%10%15%Wk 40Wk 44Wk 48Wk 52Wk 4Wk 8Wk 12Wk 16Wk 20Week of the season (the season starts in week 40)3%: end of baseline2023/24 · Week 40: 0.5% (7/1,349)2023/24 · Week 41: 1.4% (20/1,474)2023/24 · Week 42: 1.5% (27/1,754)2023/24 · Week 43: 2.0% (40/2,002)2023/24 · Week 44: 3.5% (63/1,817)2023/24 · Week 45: 4.0% (102/2,539)2023/24 · Week 46: 5.6% (152/2,700)2023/24 · Week 47: 7.9% (207/2,627)2023/24 · Week 48: 10.1% (317/3,132)2023/24 · Week 49: 11.1% (326/2,949)2023/24 · Week 50: 11.8% (386/3,259)2023/24 · Week 51: 10.5% (324/3,094)2023/24 · Week 52: 7.9% (101/1,276)2023/24 · Week 1: 8.6% (204/2,360)2023/24 · Week 2: 8.3% (262/3,167)2023/24 · Week 3: 7.5% (258/3,442)2023/24 · Week 4: 6.1% (208/3,435)2023/24 · Week 5: 5.9% (205/3,470)2023/24 · Week 6: 6.0% (221/3,662)2023/24 · Week 7: 5.1% (151/2,964)2023/24 · Week 8: 5.0% (143/2,876)2023/24 · Week 9: 5.5% (142/2,594)2023/24 · Week 10: 3.8% (90/2,361)2023/24 · Week 11: 2.9% (67/2,277)2023/24 · Week 12: 2.8% (55/1,995)2023/24 · Week 13: 2.1% (32/1,519)2023/24 · Week 14: 1.6% (24/1,518)2023/24 · Week 15: 1.6% (27/1,656)2023/24 · Week 16: 1.3% (20/1,520)2023/24 · Week 17: 0.6% (8/1,346)2023/24 · Week 18: 0.7% (8/1,162)2023/24 · Week 19: 0.2% (2/1,245)2023/24 · Week 20: 0.3% (4/1,161)2023/24 · Week 21: 0.1% (1/1,053)2024/25 · Week 40: 0.4% (7/1,693)2024/25 · Week 41: 0.4% (8/1,994)2024/25 · Week 42: 0.3% (7/2,278)2024/25 · Week 43: 0.6% (13/2,079)2024/25 · Week 44: 1.2% (23/1,867)2024/25 · Week 45: 1.7% (42/2,402)2024/25 · Week 46: 2.8% (74/2,652)2024/25 · Week 47: 4.3% (123/2,869)2024/25 · Week 48: 4.9% (143/2,931)2024/25 · Week 49: 7.2% (215/3,001)2024/25 · Week 50: 8.3% (296/3,563)2024/25 · Week 51: 8.2% (320/3,897)2024/25 · Week 52: 8.8% (129/1,467)2024/25 · Week 1: 6.8% (137/2,023)2024/25 · Week 2: 6.0% (247/4,091)2024/25 · Week 3: 5.1% (242/4,758)2024/25 · Week 4: 6.3% (334/5,327)2024/25 · Week 5: 5.7% (286/5,042)2024/25 · Week 6: 6.7% (284/4,240)2024/25 · Week 7: 7.1% (341/4,803)2024/25 · Week 8: 6.5% (264/4,062)2024/25 · Week 9: 6.4% (236/3,675)2024/25 · Week 10: 6.9% (213/3,068)2024/25 · Week 11: 7.0% (239/3,399)2024/25 · Week 12: 6.1% (184/3,018)2024/25 · Week 13: 5.6% (153/2,740)2024/25 · Week 14: 5.7% (142/2,508)2024/25 · Week 15: 5.3% (110/2,095)2024/25 · Week 16: 5.3% (64/1,202)2024/25 · Week 17: 3.0% (37/1,219)2024/25 · Week 18: 2.7% (24/879)2024/25 · Week 19: 1.6% (16/994)2024/25 · Week 20: 1.5% (15/992)2024/25 · Week 21: 1.4% (13/953)2025/26 · Week 40: 0.3% (5/1,791)2025/26 · Week 41: 0.6% (12/2,077)2025/26 · Week 42: 0.5% (12/2,211)2025/26 · Week 43: 1.4% (26/1,875)2025/26 · Week 44: 1.5% (33/2,130)2025/26 · Week 45: 1.2% (29/2,358)2025/26 · Week 46: 2.3% (61/2,598)2025/26 · Week 47: 2.9% (83/2,819)2025/26 · Week 48: 3.5% (114/3,260)2025/26 · Week 49: 4.0% (152/3,781)2025/26 · Week 50: 3.9% (143/3,655)2025/26 · Week 51: 5.2% (223/4,322)2025/26 · Week 52: 6.2% (112/1,803)2025/26 · Week 1: 6.2% (121/1,946)2025/26 · Week 2: 8.4% (229/2,712)2025/26 · Week 3: 9.4% (343/3,639)2025/26 · Week 4: 11.2% (403/3,609)2025/26 · Week 5: 12.0% (445/3,715)2025/26 · Week 6: 13.8% (444/3,229)2025/26 · Week 7: 13.3% (407/3,059)2025/26 · Week 8: 14.5% (370/2,544)2025/26 · Week 9: 12.3% (311/2,524)2025/26 · Week 10: 12.0% (230/1,910)2025/26 · Week 11: 13.6% (237/1,745)2025/26 · Week 12: 11.4% (182/1,593)2025/26 · Week 13: 9.7% (156/1,612)2025/26 · Week 14: 8.1% (96/1,184)2025/26 · Week 15: 7.8% (83/1,061)2025/26 · Week 16: 8.0% (100/1,250)2025/26 · Week 17: 4.3% (49/1,144)2025/26 · Week 18: 3.5% (36/1,021)2025/26 · Week 19: 2.8% (31/1,110)2025/26 · Week 20: 1.6% (14/876)2025/26 · Week 21: 0.9% (8/891)
Share of GP sentinel swabs positive, by week of the season. Weeks with fewer than 20 swabs are left out.
The numbers behind the chart: the last 8 weeks
GP sentinel swabs tested for RSV across the EU/EEA, by week (latest first)
WeekDatesSwabsPositiveShare positive
Week 3921–27 Sep 20261,17510.1%
Week 3814–20 Sep 20261,03000.0%
Week 377–13 Sep 202683000.0%
Week 3631 Aug – 6 Sep 202665030.5%
Week 3524–30 Aug 202652400.0%
Week 3417–23 Aug 202641000.0%
Week 3310–16 Aug 202648400.0%
Week 323–9 Aug 202645200.0%

When the last four RSV seasons started and peaked

Start = first of two weeks in a row at or above 3%; peak = highest week between week 40 and week 20
SeasonAbove 3% (2 weeks)PeakWeeks to peak
2025/26Week 48 24–30 Nov 202514.5% · Week 812
2024/25Week 47 18–24 Nov 20248.8% · Week 525
2023/24Week 44 30 Oct – 5 Nov 202311.8% · Week 506
2022/23Week 41 10–16 Oct 202218.4% · Week 476

RSV in Europe this week, country by country

Baseline 0–3%Low 3–8%Moderate 8–15%High 15–25%Very high ≥25%between seasons / too few swabsno sentinel data
Sweden: between seasons / too few swabsSpain: 0.2% · baseline · week 39Slovakia: between seasons / too few swabsSlovenia: 0.0% · baseline · small sample: 20 swabs · week 37Romania: no sentinel dataPortugal: between seasons / too few swabsPoland: between seasons / too few swabsNorway: 0.0% · baseline · small sample: 25 swabs · week 39Netherlands: 0.0% · baseline · last 4 weeks, pooledLuxembourg: 0.0% · baseline · small sample: 44 swabs · week 39Lithuania: between seasons / too few swabsLatvia: no sentinel dataItaly: between seasons / too few swabsIreland: 0.0% · baseline · small sample: 23 swabs · week 37Iceland: no sentinel dataHungary: 0.0% · baseline · week 39Greece: 0.0% · baseline · small sample: 27 swabs · week 39Germany: 0.0% · baseline · week 39France: 0.0% · baseline · week 39Finland: no sentinel dataEstonia: 0.0% · baseline · small sample: 22 swabs · week 39Denmark: 0.0% · baseline · small sample: 27 swabs · week 39Czechia: between seasons / too few swabsCyprus: 0.0% · baseline · small sample: 28 swabs · last 4 weeks, pooledCroatia: no sentinel dataBulgaria: between seasons / too few swabsBelgium: between seasons / too few swabsAustria: not tested0%0%0%0%0%0%0%0%0%0%0%
Numbers are the share of swabs positive (%). Hover or tap a country for the week and the sample size.
Share of GP sentinel swabs positive for RSV, latest week per country, highest first
CountryRSVLevelvs last weekFluCOVID-19SwabsData week
Spain0.2%Baseline▬ +0.23.9%25.9%664Wk 39
Cyprus0.0%Baseline–3.6%8.6%28Wk 36–39pooled
Denmark0.0%Baseline–3.7%0.0%27Wk 39
Estonia0.0%Baseline–0.0%0.0%22Wk 39
France0.0%Baseline▬ ±0.01.7%6.1%115Wk 39
Germany0.0%Baseline▬ ±0.00.0%0.0%85Wk 39
Greece0.0%Baseline–0.0%0.0%27Wk 39
Hungary0.0%Baseline▬ ±0.00.0%1.3%75Wk 39
Ireland0.0%Baseline–0.0%17.4%23Wk 37
Luxembourg0.0%Baseline–2.2%6.7%44Wk 39
Netherlands0.0%Baseline–7.7%5.8%52Wk 36–39pooled
Norway0.0%Baseline–0.0%4.0%25Wk 39
Slovenia0.0%Baseline–5.0%10.0%20Wk 37
Austrianot tested
Belgiumfewer than 20 swabs in the last four weeks · last data week 39
Bulgarianetwork reports in season only · last data week 13
Czechianetwork reports in season only · last data week 22
Italynetwork reports in season only · last data week 9
Lithuanianetwork reports in season only · last data week 19
Polandnetwork reports in season only · last data week 34
Portugalfewer than 20 swabs in the last four weeks · last data week 37
Slovakiafewer than 20 swabs in the last four weeks · last data week 39
Swedennetwork reports in season only · last data week 20

13 of 23 networks have a current RSV figure. Reporting in season only: Bulgaria, Czechia, Italy, Lithuania, Poland and Sweden. Too few swabs in the last four weeks: Belgium, Portugal and Slovakia.

When is RSV season?

RSV (respiratory syncytial virus) causes a cold in most older children and adults, but it is the leading cause of bronchiolitis in babies and a real risk for people over 75. In Europe it circulates mainly in winter and often peaks a few weeks before flu.

Across the EU/EEA, RSV positivity went above 3% in week 41 in 2022/23, week 44 in 2023/24, week 47 in 2024/25 and week 48 in 2025/26 and peaked at 18.4% (week 47), 11.8% (week 50), 8.8% (week 52) and 14.5% (week 8).

Positivity among GP swabs understates RSV in babies, who are mostly seen in hospital; national paediatric surveillance gives the fuller picture for young children.

Ill with flu, COVID-19 or RSV: what to do

Flu, COVID-19 and RSV cause similar symptoms: fever, cough, sore throat, aches and tiredness. Most healthy adults get better at home within one to two weeks with rest, plenty to drink and paracetamol or ibuprofen for fever and pain.

Stay at home while you have a fever and keep away from people at higher risk: babies, older people and anyone who is pregnant or has a weakened immune system. Antiviral medicines for flu work best when they are started within 48 hours of the first symptoms, so people in a higher-risk group should contact a doctor early.

See a doctor if

  • you are 65 or over, pregnant, or have recently given birth
  • you have a long-term condition, or a weakened immune system
  • you feel very unwell, or short of breath
  • your symptoms are not improving after 7 days
  • you are worried about a baby's or child's symptoms

Call 112 in an emergency

  • sudden chest pain
  • severe difficulty breathing — gasping, choking, or unable to get words out
  • coughing up blood
  • a baby who is breathing very fast, has blue lips or is unusually drowsy
Ill with flu-like symptoms?

Mobi Doctor connects you with a licensed EU-registered doctor over video, usually within 15 minutes, daily 7am–11pm CET.

How to read these numbers

Each week, GPs in every country's sentinel network take swabs from a sample of patients who come in with flu-like illness or an acute respiratory infection, and laboratories test them for influenza, SARS-CoV-2 and RSV. Test positivity is the share of those swabs that are positive. It tells you how likely it is that a flu-like illness is flu, COVID-19 or RSV right now — not how many people are ill.

For flu, below 10% is baseline: 10% is the epidemic threshold used in European sentinel surveillance. The bands above it (10–25% low, 25–40% moderate, 40–55% high, 55% and over very high), and the bands for COVID-19 (5/15/25/35%) and RSV (3/8/15/25%), are our own, so that every page uses the same scale.

Small samples swing from week to week. We leave out any week with fewer than 20 swabs, mark weeks with fewer than 50 (*), and only show a trend — a change of 3 percentage points or more against the previous week — when both weeks have at least 30. Between seasons, low-volume networks are pooled over four weeks and labelled. Only a solid weekly sample can be named Europe's highest.

The latest week is provisional: countries add late results, so a figure can still change in the next weekly release. The UK and Switzerland are not part of this dataset.

Questions people ask

Is RSV going around in Europe right now?

The RSV season has not started yet: 0.1% of 1,175 GP sentinel swabs across the EU/EEA were positive for RSV in week 39 (21–27 Sep 2026).

When is RSV season?

Across the EU/EEA, RSV rose above 3% positivity in week 41 (2022/23), week 44 (2023/24), week 47 (2024/25) and week 48 (2025/26) and peaked between week 47 and week 8.

Who is most at risk from RSV?

Babies under one year, especially those born early, and adults over 75 or with heart or lung disease. Most older children and healthy adults get a cold-like illness.

How often is this page updated?

Every week, after ECDC and WHO Europe publish the ERVISS data, usually on a Friday. The latest week is provisional.

About this page

Medical review pending

Built by the Mobi Doctor medical content team from the weekly ECDC/WHO Europe ERVISS data release. Every figure on this page is calculated from that data by the same published method each week; nothing is typed in by hand.

Medical review by Dr. Chrysoula Liakou is in progress; this page will say when it is complete.

Spotted something wrong? Tell us and we will check it against the source. Contact us

↑ Back to top